JUNE 11, 2026 AT 03:00 PM

UK's MHRA says Novo Nordisk (NOVOB DC) Semaglutide is the first GLP-1 tablet for weight loss approved in the UK

ByNewsquawk Staff

Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.

#NOVO NORDISK A/S#NOVOB.DC#EU SESSION#US SESSION#EUROPEAN EQUITIES

© 2026 Newsquawk. All rights reserved.